KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,000 | – | 1,495 | +24816.7% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 6 | -99.6% | 0.00% | – |
| Q1 2018 | $6,000 | +20.0% | 1,417 | +20.0% | 0.00% | – |
| Q4 2017 | $5,000 | -37.5% | 1,181 | -0.8% | 0.00% | -100.0% |
| Q3 2017 | $8,000 | -27.3% | 1,191 | -20.5% | 0.00% | 0.0% |
| Q2 2017 | $11,000 | -91.7% | 1,498 | -93.0% | 0.00% | -92.3% |
| Q1 2017 | $132,000 | -21.0% | 21,509 | +64.2% | 0.01% | -43.5% |
| Q1 2015 | $167,000 | -22.0% | 13,100 | -13.2% | 0.02% | -25.8% |
| Q4 2014 | $214,000 | +3.4% | 15,100 | +0.7% | 0.03% | +6.9% |
| Q3 2014 | $207,000 | +60.5% | 15,000 | +78.6% | 0.03% | +70.6% |
| Q2 2014 | $129,000 | -88.3% | 8,400 | -87.0% | 0.02% | -88.4% |
| Q1 2014 | $1,099,000 | -34.7% | 64,500 | -50.4% | 0.15% | -46.9% |
| Q4 2013 | $1,683,000 | +33.5% | 130,000 | +4.0% | 0.28% | +35.8% |
| Q3 2013 | $1,261,000 | +35.0% | 125,000 | 0.0% | 0.20% | +2.0% |
| Q2 2013 | $934,000 | +6.0% | 125,000 | 0.0% | 0.20% | +22.0% |
| Q1 2013 | $881,000 | – | 125,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |